Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Levmetamfetamine

Last content change checked dailysee data sync status

Active ingredient
Levmetamfetamine 50 mg
Reference brand
Vapor Inhaler
Dosage form
Inhalant
Route
Nasal
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2014
Label revision date
September 19, 2025
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Active ingredient
Levmetamfetamine 50 mg
Reference brand
Vapor Inhaler
Dosage form
Inhalant
Route
Nasal
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2014
Label revision date
September 19, 2025
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Product Labels (8)
Product Labels (8)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Levmetamfetamine is a nasal decongestant that comes in the form of a vapor inhaler. It is designed to provide temporary relief from nasal congestion caused by conditions such as the common cold, hay fever, and upper respiratory allergies. By inhaling the vapor, you can help clear your nasal passages and breathe more easily.

This medication works by temporarily reducing swelling in the nasal passages, allowing for easier airflow. It is important to use it as directed to achieve the best results in relieving your nasal congestion.

Uses

You can use the Vapor Inhaler for temporary relief of nasal congestion caused by the common cold, hay fever, or upper respiratory allergies. This inhalant helps to ease your breathing when you're feeling stuffy due to these conditions.

There are no known teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects associated with this product. Always consult with a healthcare professional if you have any concerns or questions about its use.

Dosage and Administration

You can use the Vapor Inhaler to help with nasal congestion. For adults and children aged 12 years and older, take 2 inhalations in each nostril. If you are supervising a child aged 6 to under 12 years, they should take 1 inhalation in each nostril.

Make sure not to use the inhaler more often than every 2 hours. If the person is under 6 years old, consult a doctor before use. Additionally, do not use this product for children under 2 years of age. Each 800 mL of air from the inhaler delivers between 0.04 to 0.150 mg of levmetamfetamine (a medication that helps relieve nasal congestion).

What to Avoid

You should avoid using the Vapor Inhaler for more than 7 days and always follow the directions provided. Frequent or prolonged use may lead to a recurrence or worsening of nasal congestion. It's important not to exceed the recommended dosage. There are no specified contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence (a condition where one relies on a substance).

Side Effects

When using the Vapor Inhaler, you may experience temporary burning, stinging, sneezing, or increased nasal discharge. Frequent or prolonged use can lead to worsening nasal congestion. It is important not to use the inhaler for more than 7 days. If your symptoms persist, stop using the product and consult a doctor.

If you are pregnant or breastfeeding, consult a healthcare professional before use. Keep the inhaler out of reach of children, and if swallowed, seek medical help or contact a Poison Control Center immediately.

Warnings and Precautions

  • Do not exceed the recommended dosage when using the Vapor Inhaler. You may experience temporary burning, stinging, sneezing, or increased nasal discharge. Using this inhaler by more than one person can spread infection.

  • Limit use to no more than 7 days and follow the directions carefully. Frequent or prolonged use may worsen nasal congestion. If you are pregnant or breastfeeding, consult a healthcare professional before use.

  • If you swallow the inhaler, seek medical help immediately or contact a Poison Control Center. Stop using the inhaler and call your doctor if your symptoms persist. Keep this product out of reach of children.

Overdose

If you accidentally swallow the contents of a vapor inhaler, it is important to seek medical help immediately or contact a Poison Control Center. Signs of an overdose may include unusual symptoms, but specific symptoms are not detailed here. Always keep inhalers out of reach of children to prevent accidental ingestion. If you suspect an overdose, do not wait for symptoms to appear; act quickly to ensure safety.

Pregnancy Use

If you are pregnant or breastfeeding, it is important to consult a healthcare professional before using this vapor inhaler. This precaution helps ensure the safety of both you and your baby, as certain substances may affect fetal development or be passed through breast milk. Always prioritize your health and your baby's well-being by seeking professional advice.

Lactation Use

If you are pregnant or breastfeeding, it is important to consult a healthcare professional before using this product. This ensures that you receive personalized advice regarding any potential effects on your health or your baby's health during lactation.

Pediatric Use

You should not use the Vapor Inhaler for children under 2 years of age. For children aged 6 to under 12 years, it is important to supervise them while they take 1 inhalation in each nostril. If your child is under 6 years old, please consult a doctor before use. For adults and children aged 12 years and older, the recommended dosage is 2 inhalations in each nostril.

Geriatric Use

When using the Vapor Inhaler, there is currently no specific information available regarding its use in older adults. This means that there are no established dosage adjustments, safety concerns, or special precautions specifically for elderly patients. As always, it is important to consult with your healthcare provider before starting any new medication to ensure it is safe and appropriate for your individual health needs.

Renal Impairment

When using the Vapor Inhaler or Levmetamfetamine, you should be aware that there is no specific information available regarding how these products may affect individuals with kidney problems. This means there are no recommended dosage adjustments, special monitoring requirements, or safety considerations outlined for patients with renal impairment. If you have kidney issues, it's always best to consult your healthcare provider for personalized advice before using these inhalants.

Hepatic Impairment

You may be wondering about the safety of using the Vapor Inhaler or Levmetamfetamine if you have liver issues. Currently, there is no specific information available regarding how these products may affect individuals with liver problems. This means there are no recommended dosage adjustments, special monitoring, or precautions outlined for patients with hepatic (liver) impairment.

If you have concerns about your liver health, it's always best to consult with your healthcare provider before using these products. They can provide personalized advice based on your medical history and current health status.

Drug Interactions

When using the Vapor Inhaler, there are no known interactions with other medications or laboratory tests. However, it's always important to discuss any medications or tests you are undergoing with your healthcare provider. This ensures that you receive safe and effective care tailored to your specific health needs. Always keep your provider informed about all the products you are using to avoid any potential issues.

Storage and Handling

To ensure the best performance of your Vapor Inhaler, store it in a cool, dry place at temperatures between 59°-86° F (15°-30° C). Always keep the inhaler tightly closed when not in use to maintain its effectiveness. You can expect it to remain effective for at least three months after you first use it.

When it comes to disposal, follow local regulations for disposing of inhalers or medications. If you're unsure, consult your pharmacist for guidance on safe disposal methods.

FAQ

What is Levmetamfetamine used for?

Levmetamfetamine is a nasal decongestant used for temporary relief of nasal congestion due to the common cold, hay fever, and upper respiratory allergies.

How should I use Levmetamfetamine?

For adults and children 12 years and older, use 2 inhalations in each nostril. For children aged 6 to under 12 years, use 1 inhalation in each nostril with adult supervision.

Are there any age restrictions for using Levmetamfetamine?

Children under 2 years of age should not use this product, and those under 6 years should consult a doctor.

What are the warnings associated with Levmetamfetamine?

Warnings include potential temporary burning, stinging, sneezing, or increased nasal discharge. Do not exceed the recommended dosage and do not use for more than 7 days.

What should I do if symptoms persist?

If symptoms persist, stop using Levmetamfetamine and consult a doctor.

Can I use Levmetamfetamine if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, consult a health professional before using Levmetamfetamine.

What should I do in case of accidental ingestion?

If swallowed, seek medical help or contact a Poison Control Center immediately.

How should I store Levmetamfetamine?

Store Levmetamfetamine at 59°-86° F (15°-30° C) and keep the inhaler tightly closed.

What are the side effects of using Levmetamfetamine?

Temporary burning, stinging, sneezing, or increased nasal discharge may occur. Frequent or prolonged use may cause nasal congestion to recur or worsen.

How often can I use Levmetamfetamine?

You should not use Levmetamfetamine more often than every 2 hours and not for more than 7 days.

How long is Levmetamfetamine effective after first use?

This inhaler is effective for a minimum of 3 months after first use.

Uses and Indications

This drug is indicated for the temporary relief of nasal congestion due to the following conditions:

  • The common cold

  • Hay fever

  • Upper respiratory allergies

Limitations of Use: There are no teratogenic or nonteratogenic effects mentioned.

Dosage and Administration

The product is administered via inhalation, delivering 0.04 to 0.150 mg of levmetamfetamine in each 800 mL of air.

For adults and children aged 12 years and older, the recommended dosage is 2 inhalations in each nostril. For children aged 6 to under 12 years, 1 inhalation in each nostril is advised, and this should be done under adult supervision.

It is important to note that the product should not be used more frequently than every 2 hours. For children under 6 years of age, it is recommended to consult a doctor before use. The product is contraindicated in children under 2 years of age.

Contraindications

There are no contraindications specified for the Vapor Inhaler or Levmetamfetamine. It is advised that the product should not be used for more than 7 days and should be used only as directed. Frequent or prolonged use may lead to a recurrence or worsening of nasal congestion. Additionally, it is important not to exceed the recommended dosage.

Warnings and Precautions

Warnings

  • Do not exceed the recommended dosage.

  • Temporary burning, stinging, sneezing, or increased nasal discharge may occur.

  • Use of this container by more than one person may spread infection.

  • Do not use for more than 7 days; use only as directed.

  • Frequent or prolonged use may cause nasal congestion to recur or worsen.

General Precautions

  • If pregnant or breast-feeding, ask a health professional before use.

  • Keep out of reach of children.

Get Emergency Medical Help

  • If swallowed, get medical help or contact a Poison Control Center right away.

Stop Taking and Call Your Doctor

  • Stop use and ask a doctor if symptoms persist.

Side Effects

Temporary burning, stinging, sneezing, or increased nasal discharge may occur in patients using the Vapor Inhaler. These reactions are generally mild and transient.

Frequent or prolonged use of the inhaler may lead to a recurrence or worsening of nasal congestion. It is advised that patients do not use the product for more than 7 days to mitigate this risk.

Patients are instructed to stop use and consult a healthcare professional if symptoms persist. Additionally, if the product is ingested, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

For pregnant or breastfeeding individuals, it is essential to consult a healthcare professional before using the product.

Furthermore, the inhaler should be kept out of reach of children to prevent accidental ingestion. Use of the inhaler by more than one person may also pose a risk of spreading infection.

Drug Interactions

The Vapor Inhaler has no documented drug interactions. Additionally, there is no information available regarding interactions with laboratory tests. Therefore, healthcare professionals can consider the use of this inhalant without concerns of known interactions with other medications or diagnostic tests.

Pediatric Use

Children under 2 years of age should not use the Vapor Inhaler. For children aged 6 to under 12 years, the recommended dosage is 1 inhalation in each nostril, administered with adult supervision. For adults and children aged 12 years and over, the dosage is 2 inhalations in each nostril. For children under 6 years of age, it is advised to consult a doctor before use.

Geriatric Use

Elderly patients may use the Vapor Inhaler; however, the product insert does not provide specific information regarding dosage adjustments, safety concerns, or special precautions for this population. Healthcare professionals should exercise clinical judgment when prescribing this inhalant to geriatric patients, considering individual health status and potential comorbidities. Regular monitoring may be warranted to ensure safety and efficacy in this demographic.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using the Vapor Inhaler or Levmetamfetamine. There is limited data on the safety of these inhalants during pregnancy and lactation, and the potential risks to fetal outcomes or breastfeeding infants are not well established. Therefore, it is essential for healthcare providers to evaluate the benefits and risks on a case-by-case basis before recommending use in these populations.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using the Vapor Inhaler. There is limited data available regarding the excretion of the product in breast milk and its potential effects on breastfed infants. Therefore, caution is recommended to ensure the safety and well-being of both the mother and the infant during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available labeling for the Vapor Inhaler and Levmetamfetamine. The inserts do not provide information regarding dosage adjustments, special monitoring, or safety considerations for individuals with reduced kidney function. As such, healthcare professionals should exercise caution and consider individual patient circumstances when prescribing these medications to patients with renal impairment, given the absence of specific guidance in the product labeling.

Hepatic Impairment

Patients with hepatic impairment have no specific information regarding dosage adjustments, special monitoring, or precautions provided in the drug insert for the Vapor Inhaler and Levmetamfetamine. Therefore, it is recommended that healthcare professionals exercise caution when prescribing these medications to patients with liver problems, as the lack of data may necessitate individualized assessment and monitoring based on the patient's clinical status.

Overdosage

In the event of an overdose involving the Vapor Inhaler or Levmetamfetamine, immediate medical assistance is crucial. If the product is swallowed, it is imperative to seek medical help or contact a Poison Control Center without delay.

Symptoms of overdose may include various adverse effects, although specific symptoms are not detailed in the available data. Continuous monitoring of the patient is recommended to assess any potential complications that may arise from the overdose.

Additionally, it is essential to keep the product out of reach of children to prevent accidental ingestion. Prompt intervention and appropriate medical care are vital in managing any overdose situation effectively.

Nonclinical Toxicology

Teratogenicity

No information regarding teratogenic effects has been provided in the available data.

Carcinogenesis, Mutagenesis, Impairment of Fertility

There is no information available concerning carcinogenicity, mutagenicity, or impairment of fertility in the nonclinical studies.

Animal Toxicology

No specific data on animal pharmacology and toxicology has been provided.

Storage and Handling

This Vapor Inhaler is supplied in an inhalant form and is effective for a minimum of 3 months after first use. It is essential to keep the inhaler tightly closed to maintain its efficacy.

For optimal storage, the inhaler should be kept at a temperature range of 59°-86° F (15°-30° C). Proper adherence to these storage conditions will help ensure the product remains effective throughout its intended use period.

Product Labels

The table below lists all over-the-counter labels containing levmetamfetamine. Use it to compare dosage forms, strengths, and uses across products.

FDA-Approved Levmetamfetamine Labels (Originator & Generics) showing branded and generic formulations with forms, routes, strengths, and FDA approval years.
More Details
Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It consolidates data from 8 FDA Structured Product Labels (DailyMed) for Levmetamfetamine (marketed as Vapor Inhaler), with data retrieved by a validated AI data-extraction workflow. This includes 8 distinct product formulations. All FDA-listed dosage forms and strengths are aggregated in the sections above. Regulatory status appears in the Summary Information panel and was verified in the FDA National Drug Code directory. Detailed product-specific information is available via the individual label pages linked above. No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.